General — clinical cases
30 questions
Sample cases
- Case 1
A 66-year-old man has heart failure with reduced ejection fraction (LVEF 30%, NYHA class II). He does not have diabetes. He takes sacubitril-valsartan 97/103 mg twice daily, bisoprolol 10 mg daily and spironolactone 25 mg daily, all tolerated. BP 112/70 mmHg, potassium 4.6 mmol/L (4.6 mEq/L), eGFR 58 mL/min/1.73 m². Which change is most appropriate to further reduce his risk of heart-failure hospitalization and cardiovascular death?
- A.Add dapagliflozin 10 mg once daily
- B.Add digoxin 0.125 mg once daily
- C.Add hydralazine plus isosorbide dinitrate
- D.Add sitagliptin 100 mg once daily
- Case 2
An 82-year-old woman with non-valvular atrial fibrillation is starting apixaban for stroke prevention. Weight 58 kg, serum creatinine 97 µmol/L (1.1 mg/dL). She has no interacting medications and no active bleeding. Which apixaban regimen is appropriate?
- A.5 mg twice daily
- B.2.5 mg twice daily
- C.2.5 mg once daily
- D.5 mg once daily
- Case 3
A 58-year-old man has an average automated office BP of 148/92 mmHg confirmed by home monitoring. He has no diabetes, kidney disease or cardiovascular disease, and lifestyle changes over 3 months have not lowered his BP. According to the 2025 Hypertension Canada primary care guideline, which initial approach and systolic target are recommended?
- A.Single-drug therapy with a thiazide diuretic; target BP below 140/90 mmHg
- B.Single-drug therapy with an ACE inhibitor; target systolic BP below 120 mmHg
- C.Low-dose two-drug single-pill combination; target systolic BP below 130 mmHg
- D.Low-dose two-drug single-pill combination; target BP below 140/90 mmHg
